Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fujifilm Diosynth Biotechnologies USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014266
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermentation, cell culture systems, insect cells and transgenic sources. It offers cell line strain development, process development, CGMP contract manufacturing, and other services. Fujifilm Diosynth’s activities include system development of mammalian, yeast, insect systems, microbial, viral vectors and virus replication host platforms. The organization serves biopharmaceutical industries in the US and the UK. Fujifilm Diosynth is headquartered in Morrisville, North Carolina, the US.

Fujifilm Diosynth Biotechnologies USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deal Details 9
Acquisition 9
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 9
Mitsubishi Acquires 20% Stake In Fujifilm Diosynth Biotechnologies U.S.A. And Fujifilm Diosynth Biotechnologies UK 10
Fujifilm Completes Acquisition Of Diosynth 11
Fujifilm Diosynth Biotechnologies USA Inc – Key Competitors 12
Fujifilm Diosynth Biotechnologies USA Inc – Key Employees 13
Fujifilm Diosynth Biotechnologies USA Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 15
Strategy And Business Planning 15
May 09, 2016: Fujifilm Diosynth Biotechnologies opens new laboratory facility in Research Triangle Park, NC 15
Product News 16
Oct 03, 2017: Bio-Ess Laboratories and FUJIFILM Diosynth Biotechnologies Find That Cell-Ess Media Supplement Improves Viral Production for Vaccine 16
Other Significant Developments 17
Mar 01, 2017: FUJIFILM Diosynth Biotechnologies Announces New Service Offering to Support Development and cGMP Monoclonal Antibody Production 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 9
Mitsubishi Acquires 20% Stake In Fujifilm Diosynth Biotechnologies U.S.A. And Fujifilm Diosynth Biotechnologies UK 10
Fujifilm Completes Acquisition Of Diosynth 11
Fujifilm Diosynth Biotechnologies USA Inc, Key Competitors 12
Fujifilm Diosynth Biotechnologies USA Inc, Key Employees 13
Fujifilm Diosynth Biotechnologies USA Inc, Other Locations 14

★海外企業調査レポート[Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centene Corporation:企業の戦略・SWOT・財務情報
    Centene Corporation - Strategy, SWOT and Corporate Finance Report Summary Centene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Solvay S.A:企業の戦略・SWOT・財務分析
    Solvay S.A - Strategy, SWOT and Corporate Finance Report Summary Solvay S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lyka Labs Ltd (LYKALABS):企業の財務・戦略的SWOT分析
    Summary Lyka Labs Ltd (Lyka Labs) is a manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company provides formulations such as lyophilized injections, topical formulations of cream, ointment, foams, gels and lotions. It offers formulation research and development …
  • Boston-Power, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Boston-Power, Inc. (Boston-Power) is a developer and manufacturer of lithium-ion battery and pack technologies. The company provides rechargeable lithium-ion cells under two brands, namely, Sonata and Swing. Its Sonata product range finds application in portable power and notebook computer m …
  • Bureau Veritas SA (BVI)-エネルギー分野:企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Synopsys, Inc.:戦略・SWOT・企業財務分析
    Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Oberoi Realty Limited:企業の戦略・SWOT・財務情報
    Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report Summary Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Indiana Resources Limited:企業の戦略・SWOT・財務分析
    Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nanolek-製薬・医療分野:企業M&A・提携分析
    Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek a …
  • NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析
    NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Industrial Bank Of Korea:企業の戦略・SWOT・財務分析
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • American Caresource Holdings Inc (GNOW)-製薬・医療分野:企業M&A・提携分析
    Summary American Caresource Holdings Inc (ACS) is a healthcare service provider that offers urgent and primary care services. The center’s services include urgent care, veterans care, primary care, and occupational health services. Its urgent care services offer treatment for chest pain, abdominal p …
  • 1-800-FLOWERS.COM, Inc.:企業の戦略・SWOT・財務情報
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Taiwan Shin Kong Commercial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Shin Kong Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • NorSea Group AS:企業の戦略的SWOT分析
    NorSea Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • The Interpublic Group of Companies, Inc.:戦略・SWOT・企業財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Zhejiang Geely Holding Group Co Ltd:企業のM&A・事業提携・投資動向
    Zhejiang Geely Holding Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zhejiang Geely Holding Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Avanir Pharmaceuticals Inc:企業の戦略的SWOT分析
    Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆